Structural and biochemical characterization of MepR, a multidrug binding transcription regulator of the Staphylococcus aureus multidrug efflux pump MepA.

Nucleic Acids Research
Muthiah KumaraswamiR G Brennan

Abstract

MepR is a multidrug binding transcription regulator that represses expression of the Staphylococcus aureus multidrug efflux pump gene, mepA, as well as its own gene. MepR is induced by multiple cationic toxins, which are also substrates of MepA. In order to understand the gene regulatory and drug-binding mechanisms of MepR, we carried out biochemical, in vivo and structural studies. The 2.40 A resolution structure of drug-free MepR reveals the most open MarR family protein conformation to date, which will require a huge conformational change to bind cognate DNA. DNA-binding data show that MepR uses a dual regulatory binding mode as the repressor binds the mepA operator as a dimer of dimers, but binds the mepR operator as a single dimer. Alignment of the six half sites reveals the consensus MepR binding site, 5'-GTTAGAT-3'. 'Drug' binding studies show that MepR binds to ethidium and DAPI with comparable affinities (K(d) = 2.6 and 4.5 microM, respectively), but with significantly lower affinity to the larger rhodamine 6G (K(d) = 62.6 microM). Mapping clinically relevant or in vitro selected MepR mutants onto the MepR structure suggests that their defective repressor phenotypes are due to structural and allosteric defects.

References

Mar 1, 1991·Acta Crystallographica. Section A, Foundations of Crystallography·T A JonesM Kjeldgaard
Oct 3, 1998·Acta Crystallographica. Section D, Biological Crystallography·A T BrüngerG L Warren
Mar 25, 1999·Acta Crystallographica. Section D, Biological Crystallography·T C Terwilliger, J Berendzen
Aug 10, 1999·Journal of Bacteriology·A BroounK Lewis
Oct 26, 1999·Acta Crystallographica. Section D, Biological Crystallography·T C Terwilliger
Feb 19, 2000·Current Opinion in Structural Biology·K S Gajiwala, S K Burley
Feb 24, 2001·Cellular and Molecular Life Sciences : CMLS·T KöhlerP Plésiat
Dec 12, 2001·Science·M A SchumacherR G Brennan
Feb 13, 2002·Current Opinion in Structural Biology·Warren L DeLano
Feb 13, 2002·Current Opinion in Structural Biology·Joy L Huffman, Richard G Brennan
May 30, 2002·The Journal of Biological Chemistry·Daniel LimNatalie C J Strynadka
Jul 24, 2002·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Parjit Kaur
Aug 16, 2002·Molecular Microbiology·Maria A Schumacher, Richard G Brennan
Nov 7, 2003·Nucleic Acids Research·Beatriz GalánMaría A Prieto
Sep 1, 1994·Acta Crystallographica. Section D, Biological Crystallography·UNKNOWN Collaborative Computational Project, Number 4
Dec 2, 2004·Acta Crystallographica. Section D, Biological Crystallography·Paul Emsley, Kevin Cowtan
Jun 22, 2005·Journal of Molecular Biology·Steven P Wilkinson, Anne Grove
Oct 13, 2005·Expert Opinion on Pharmacotherapy·Abhijit M Bal, Ian M Gould
Dec 22, 2005·Acta Crystallographica. Section D, Biological Crystallography·Andrew G W Leslie
Mar 15, 2006·Current Opinion in Microbiology·Damon W Ellison, Virginia L Miller
Jun 1, 2006·The American Journal of Medicine·Louis B Rice
Jul 4, 2006·American Journal of Infection Control·Louis B Rice
May 1, 2007·Journal of Molecular Biology·Yilmaz AlguelXiaodong Zhang
Jun 20, 2007·Antimicrobial Agents and Chemotherapy·Carmen E DeMarcoGlenn W Kaatz
Nov 29, 2007·Molecular Cell·Kate J NewberryRichard G Brennan
Sep 25, 2008·Proceedings of the National Academy of Sciences of the United States of America·Mark S WilkeNatalie C J Strynadka

❮ Previous
Next ❯

Citations

Nov 17, 2011·Journal of the American Chemical Society·Alfredo J GuerraDavid P Giedroc
Mar 24, 2010·The Journal of Biological Chemistry·Fernando A PagliaiGraciela L Lorca
Aug 19, 2010·Journal of Molecular Cell Biology·Inoka C Perera, Anne Grove
Sep 6, 2012·Acta Crystallographica. Section D, Biological Crystallography·Jin-Yi ZhuBi-Cheng Wang
Aug 15, 2009·Drugs·Xian-Zhi Li, Hiroshi Nikaido
Jun 11, 2014·Acta Crystallographica. Section D, Biological Crystallography·Kevin PröpperIsabel Usón
Jul 4, 2017·Critical Reviews in Biochemistry and Molecular Biology·Dinesh K Deochand, Anne Grove
Oct 19, 2017·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Andrei Nicoli Gebieluca DabulIlana Lopes Baratella Cunha Camargo
Apr 10, 2013·The Open Microbiology Journal·Sofia Santos CostaIsabel Couto
Jul 17, 2019·Antioxidants & Redox Signaling·Verena Nadin FritschHaike Antelmann
Nov 5, 2019·Protein Science : a Publication of the Protein Society·Grace A BeggsMehreen Arshad
Jan 6, 2016·The Journal of Microbiology·Soojin Jang
Apr 30, 2016·The Journal of Biological Chemistry·Youngchang KimAndrzej Joachimiak
Jul 21, 2015·Annals of the New York Academy of Sciences·David C Hooper, George A Jacoby
Dec 13, 2017·Proceedings of the National Academy of Sciences of the United States of America·Rongfeng ZhuPeng R Chen
Jul 28, 2016·Cold Spring Harbor Perspectives in Medicine·David C Hooper, George A Jacoby
Jun 29, 2010·Current Opinion in Structural Biology·Herschel Wade

❮ Previous
Next ❯

Methods Mentioned

BETA
gel-filtration
in vivo transcription assay
size exclusion chromatography

Software Mentioned

SigmaPlot
MOSFLM
SCALA
RESOLVE
Coot
SOLVE
ClustalW
CNS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.